Carrier
Screening Market, by Test Type (Expanded Carrier Screening and Targeted
Disease Carrier Screening), by Disease Type (Cystic Fibrosis, Sickle Cell
Disease, Spinal Muscular Atrophy, Fragile X Syndrome, Thalassemia, and Others),
by End User (Hospitals, Reference Laboratories, and Others), and by Region
(North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -
Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
Genetic disorders are diseases
caused due to change in the normal DNA sequence. These changes are known as
mutations, which can occur in one or multiple genes. A person carries genes in
pair, one from each parent. The person carrying the mutated gene for the
genetic disorder is known as the carrier. If both the parents are carriers of
the gene associated with the genetic disorder, then there is 25% chance that
the child will be born with the disorder. If only one parent is the carrier of
the mutated gene then there is 50% chance that the child will be carrying the
mutated gene.
Carrier screening is a type of
test which helps in determining the risk of having a child with a genetic
disease. Carrier screening determines whether a healthy person carries the
recessive gene of genetic diseases such as cystic fibrosis, sickle cell
disease, and others.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/3500
Global Carrier Screening Market –
Dynamics
Rising mergers, agreements, and
acquisitions by market players are expected to drive the global carrier
screening market over the forecast period. For instance, in July 2017, Counsyl,
Inc., entered into an expanded agreement with Angsana Molecular &
Diagnostics Laboratory, a multinational laboratory services company, to
commercialize expanded carrier screening (ECS) test in Hong Kong. Furthermore,
in July 2018, Counsyl, Inc. was acquired by Myriad Genetics, Inc. The
acquisition is expected to strengthen the genetic tests portfolio of Myriad
Genetics, Inc.
Moreover, various launches and
approvals of new carrier screening tests are likely to propel growth of the
carrier screening market during the forecast period. For instance, in June
2018, Invitae Corporation, announced the launch of Invitae Carrier Screen,
which is a test designed for enhanced risk assessment to determine the
possibility of the child having a genetic disorder.
Global Carrier Screening Market –
Regional Insights
North America accounted for the
largest market share in 2018, owing to product approvals and launches of new
carrier screening tests in the region. For instance, in October 2019, Sema4,
announced the launch of Expanded Carrier Screen, a test which determines the
risk of an inherited genetic disorder in the child.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/carrier-screening-market-3500
Europe is also witnessing
lucrative growth in the carrier screening market owing to launches and
approvals of new screening tests in the region. For instance, in June 2019,
QIAGEN, a German provider of sample and assay technologies for molecular
diagnostics, launched QIAseq Expanded Carrier Screening Panel. The QIAseq
provides information about the targets and genes that are responsible for 200 disease
indications.
Global Carrier Screening Market –
Competitive landscape
Key players operating in the
global carrier screening market include Invitae Corporation, Thermo Fisher
Scientific, Quest Diagnostics, Sema4, Myriad Genetics, Inc., Illumina, Inc.,
Fulgent Genetics, Gene by Gene, CENTOGENE N.V., QIAGEN, Eurofins Scientific,
Luminex Corporation, Medgenome, and others.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/3500
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and
competitive analysis through various recommendations related to emerging market
trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment